Combined therapy against tumors comprising substituted...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/70 (2006.01) A61K 31/00 (2006.01) A61K 31/335 (2006.01) A61K 31/40 (2006.01) A61K 31/475 (2006.01) A61K 31/505 (2006.01) A61K 31/565 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2411172

The present invention provides the combined use of acryloyl distamycin derivatives, in particular .alpha.-bromo- and .alpha.-chloro-acryloyl distamycin derivatives of formula (I), as set forth in the specification, and an antineoplastic topoisomerase I or II inhibitor, in the treatment of tumors. Also provided is the use of the said combinations in the treatment or prevention of metastasis or in the treatment of tumors by inhibition of angiogenesis.

Cette invention a trait à l'utilisation combinée, aux fins du traitement de tumeurs, de dérivés de distamycine acryloyle, notamment de dérivés de alpha -bromo et de alpha -chloro distamycine acryloyle correspondant à la formule (I), comme définie dans le descriptif, et d'un inhibiteur de la topoisomérase I ou II à action antinéoplasique. L'invention concerne également l'utilisation de ces combinaisons pour le traitement ou la prévention des métastases ou encore pour le traitement de tumeurs par inhibition de l'angiogenèse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combined therapy against tumors comprising substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined therapy against tumors comprising substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined therapy against tumors comprising substituted... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1341623

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.